Tamar Thompson - 25 May 2023 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Tamar Thompson
Issuer symbol
CPRX
Transactions as of
25 May 2023
Net transactions value
$0
Form type
3
Filing time
05 Jun 2023, 17:00:18 UTC
Previous filing
17 Jun 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPRX Options to purchase Common Stock 25 May 2023 Common Stock 40,000 $11.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest in three equal tranches on May 25, 2024, 2025 and 2026.